The Impact of Gene Polymorphisms on Anticoagulation Control With Warfarin.

about

The Impact of Gene Polymorphisms on Anticoagulation Control With Warfarin.

Item

http://www.wikidata.org/entity/Q48665970

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The Impact of Gene Polymorphisms on Anticoagulation Control With Warfarin.

@en

The Impact of Gene Polymorphisms on Anticoagulation Control With Warfarin.

@nl

type

Item

label

The Impact of Gene Polymorphisms on Anticoagulation Control With Warfarin.

@en

The Impact of Gene Polymorphisms on Anticoagulation Control With Warfarin.

@nl

prefLabel

The Impact of Gene Polymorphisms on Anticoagulation Control With Warfarin.

@en

The Impact of Gene Polymorphisms on Anticoagulation Control With Warfarin.

@nl

P1476

The Impact of Gene Polymorphisms on Anticoagulation Control With Warfarin

@en

P2093

Hai He Jiang

http://www.w3.org/2001/XMLSchema#string

Hui Ming Ye

http://www.w3.org/2001/XMLSchema#string

Jia Liu

http://www.w3.org/2001/XMLSchema#string

Lian Sheng Wang

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Xi Li

http://www.w3.org/2001/XMLSchema#string

Ya Xing Zhou

http://www.w3.org/2001/XMLSchema#string

Yi Chen Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis

The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study

National estimates of emergency department visits for hemorrhage-related adverse events from clopidogrel plus aspirin and from warfarin.

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action.

Pharmacogenetics of target genes across the warfarin pharmacological pathway.

Impact of the CYP4F2 gene polymorphisms on the warfarin maintenance dose: A systematic review and meta-analysis

Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues.

The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics.

G-1639A but Not C1173T VKORC1 Gene Polymorphism Is Related to Ischemic Stroke and Its Various Risk Factors in Ukrainian Population.

Warfarin Dosing and Time Required to Reach Therapeutic International Normalized Ratio in Patients with Hypercoagulable Conditions.

P304

640-646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029617703483

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28401802

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

6714698

http://www.w3.org/2001/XMLSchema#string